Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llad003
Abstract: Hidradenitis suppurativa (HS) as a paradoxical adverse event (PAE) using anti-IL1 has not been reported in the literature. We herein report a case of paradoxical hidradenitis suppurativa due to anti-IL1 agents for mevalonate kinase deficiency… read more here.
Keywords: due anti; agents mevalonate; hidradenitis suppurativa; hidradenitis ... See more keywords